Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (F32 DE026688, T90DE02198, R01DE023836)
Received: 25 January 2018
Accepted: 17 July 2018
First Online: 11 September 2018
: Dr. Cowley is employed by, has equity ownership in, and serves on the board of directors of TransViragen, the company which has been contracted by UNC-Chapel Hill to manage its Animal Models Core Facility. The remaining authors declare no competing interests.